Next Article in Journal
Geographic Variations and the Associated Factors in Adherence to and Persistence with Adjuvant Hormonal Therapy for the Privately Insured women Aged 18–64 with Breast Cancer in Texas
Next Article in Special Issue
Novel Therapeutics in Ovarian Cancer: Expanding the Toolbox
Previous Article in Journal
Development of a Multi-Criteria Decision Analysis Rating Tool to Prioritize Real-World Evidence Questions for the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration
Previous Article in Special Issue
Oncologic Outcomes of Surgically Treated Cervical Cancer with No Residual Disease on Hysterectomy Specimen: A 4C (Canadian Cervical Cancer Collaborative) Working Group Study
 
 
Article

Article Versions Notes

Curr. Oncol. 2023, 30(4), 3787-3799; https://doi.org/10.3390/curroncol30040287
Action Date Notes Link
article xml file uploaded 29 March 2023 10:19 CEST Original file -
article xml uploaded. 29 March 2023 10:19 CEST Update -
article pdf uploaded. 29 March 2023 10:19 CEST Version of Record -
article supplementary file uploaded. 29 March 2023 10:19 CEST - https://www.mdpi.com/1718-7729/30/4/287#supplementary
article html file updated 29 March 2023 10:20 CEST Original file -
article xml file uploaded 29 March 2023 11:22 CEST Update -
article xml uploaded. 29 March 2023 11:22 CEST Update https://www.mdpi.com/1718-7729/30/4/287/xml
article pdf uploaded. 29 March 2023 11:22 CEST Updated version of record https://www.mdpi.com/1718-7729/30/4/287/pdf
article html file updated 29 March 2023 11:23 CEST Update -
article html file updated 6 April 2023 23:26 CEST Update https://www.mdpi.com/1718-7729/30/4/287/html
Back to TopTop